430 related articles for article (PubMed ID: 29568237)
1. Resistance a major hindrance to chemotherapy in hepatocellular carcinoma: an insight.
Lohitesh K; Chowdhury R; Mukherjee S
Cancer Cell Int; 2018; 18():44. PubMed ID: 29568237
[TBL] [Abstract][Full Text] [Related]
2. Noncoding RNA-mediated molecular bases of chemotherapy resistance in hepatocellular carcinoma.
He Q; Guo P; Bo Z; Yu H; Yang J; Wang Y; Chen G
Cancer Cell Int; 2022 Aug; 22(1):249. PubMed ID: 35945536
[TBL] [Abstract][Full Text] [Related]
3. Autophagy orchestrates resistance in hepatocellular carcinoma cells.
Seydi H; Nouri K; Rezaei N; Tamimi A; Hassan M; Mirzaei H; Vosough M
Biomed Pharmacother; 2023 May; 161():114487. PubMed ID: 36963361
[TBL] [Abstract][Full Text] [Related]
4. Secretory Clusterin: A Promising Target for Chemoresistance of Hepatocellular Carcinoma.
Zhang J; Wu M; Xu Y; Song Q; Zheng W
Mini Rev Med Chem; 2020; 20(12):1153-1165. PubMed ID: 32228422
[TBL] [Abstract][Full Text] [Related]
5. A novel strategy for the diagnosis, prognosis, treatment, and chemoresistance of hepatocellular carcinoma: DNA methylation.
Liu A; Wu Q; Peng D; Ares I; Anadón A; Lopez-Torres B; Martínez-Larrañaga MR; Wang X; Martínez MA
Med Res Rev; 2020 Sep; 40(5):1973-2018. PubMed ID: 32525219
[TBL] [Abstract][Full Text] [Related]
6. Targeting autophagy in chemotherapy-resistant of hepatocellular carcinoma.
Sheng J; Qin H; Zhang K; Li B; Zhang X
Am J Cancer Res; 2018; 8(3):354-365. PubMed ID: 29636994
[TBL] [Abstract][Full Text] [Related]
7. Targeting and regulation of autophagy in hepatocellular carcinoma: revisiting the molecular interactions and mechanisms for new therapy approaches.
Hashemi M; Nadafzadeh N; Imani MH; Rajabi R; Ziaolhagh S; Bayanzadeh SD; Norouzi R; Rafiei R; Koohpar ZK; Raei B; Zandieh MA; Salimimoghadam S; Entezari M; Taheriazam A; Alexiou A; Papadakis M; Tan SC
Cell Commun Signal; 2023 Feb; 21(1):32. PubMed ID: 36759819
[TBL] [Abstract][Full Text] [Related]
8. Multifaceted role of NF-κB in hepatocellular carcinoma therapy: Molecular landscape, therapeutic compounds and nanomaterial approaches.
Gupta R; Kadhim MM; Turki Jalil A; Obayes AM; Aminov Z; Alsaikhan F; Ramírez-Coronel AA; Ramaiah P; Tayyib NA; Luo X
Environ Res; 2023 Jul; 228():115767. PubMed ID: 36966991
[TBL] [Abstract][Full Text] [Related]
9. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
Huang WC; Tung SL; Chen YL; Chen PM; Chu PY
BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298
[TBL] [Abstract][Full Text] [Related]
10. HMGB1 Promotes Resistance to Doxorubicin in Human Hepatocellular Carcinoma Cells by Inducing Autophagy
Li J; Zhou W; Mao Q; Gao D; Xiong L; Hu X; Zheng Y; Xu X
Front Oncol; 2021; 11():739145. PubMed ID: 34778055
[TBL] [Abstract][Full Text] [Related]
11. Role of sirtuin 1 (SIRT1) in regulation of autophagy and nuclear factor-kappa Beta (NF-ĸβ) pathways in sorafenib-resistant hepatocellular carcinoma (HCC).
Chan HY; Ramasamy TS; Chung FF; Teow SY
Cell Biochem Biophys; 2024 Mar; ():. PubMed ID: 38466472
[TBL] [Abstract][Full Text] [Related]
12. Trefoil factor 3 mediation of oncogenicity and chemoresistance in hepatocellular carcinoma is AKT-BCL-2 dependent.
You ML; Chen YJ; Chong QY; Wu MM; Pandey V; Chen RM; Liu L; Ma L; Wu ZS; Zhu T; Lobie PE
Oncotarget; 2017 Jun; 8(24):39323-39344. PubMed ID: 28445151
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of eukaryotic translation initiation factor 5A2 enhances the therapeutic efficiency of doxorubicin in hepatocellular carcinoma cells by triggering lethal autophagy.
Tang Y; Chen K; Luan X; Zhang J; Liu R; Zheng X; Xie S; Ke H; Zhang X; Chen W
Int J Oncol; 2020 Dec; 57(6):1368-1380. PubMed ID: 33174013
[TBL] [Abstract][Full Text] [Related]
14. The Emerging Roles of Exosomes in the Chemoresistance of Hepatocellular Carcinoma.
Zhang J; Song Q; Wu M; Zheng W
Curr Med Chem; 2021; 28(1):93-109. PubMed ID: 32000636
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs contribute to ATP-binding cassette transporter- and autophagy-mediated chemoresistance in hepatocellular carcinoma.
Espelt MV; Bacigalupo ML; Carabias P; Troncoso MF
World J Hepatol; 2019 Apr; 11(4):344-358. PubMed ID: 31114639
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance and functional role of transmembrane protein 47 (TMEM47) in chemoresistance of hepatocellular carcinoma.
Ng KT; Yeung OW; Liu J; Li CX; Liu H; Liu XB; Qi X; Ma YY; Lam YF; Lau MY; Qiu WQ; Shiu HC; Lai MK; Lo CM; Man K
Int J Oncol; 2020 Oct; 57(4):956-966. PubMed ID: 32945373
[TBL] [Abstract][Full Text] [Related]
17. Peptidylarginine deiminase IV promotes the development of chemoresistance through inducing autophagy in hepatocellular carcinoma.
Fan T; Zhang C; Zong M; Zhao Q; Yang X; Hao C; Zhang H; Yu S; Guo J; Gong R; Fan S; Wei L; Fan L
Cell Biosci; 2014; 4():49. PubMed ID: 25922661
[TBL] [Abstract][Full Text] [Related]
18. ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1α.
Wu FQ; Fang T; Yu LX; Lv GS; Lv HW; Liang D; Li T; Wang CZ; Tan YX; Ding J; Chen Y; Tang L; Guo LN; Tang SH; Yang W; Wang HY
J Hepatol; 2016 Aug; 65(2):314-24. PubMed ID: 27154061
[TBL] [Abstract][Full Text] [Related]
19. Dimeric oxyberberine CT4-1 targets LINC02331 to induce cytotoxicity and inhibit chemoresistance via suppressing Wnt/β-catenin signaling in hepatocellular carcinoma.
Lin X; Chen J; Li X; Chen D; Luo K; Deng Y; Yang D; Huang Z; Tao C
Arch Toxicol; 2023 Jun; 97(6):1627-1647. PubMed ID: 37120773
[TBL] [Abstract][Full Text] [Related]
20. RCC2 contributes to tumor invasion and chemoresistance to cisplatin in hepatocellular carcinoma.
Chen Q; Jiang P; Jia B; Liu Y; Zhang Z
Hum Cell; 2020 Jul; 33(3):709-720. PubMed ID: 32239438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
